PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine, Launceston General Hospital, Tasmania, Australia; Department of Neurology, Launceston General Hospital, Tasmania, Australia; Faculty of Medicine, University of Tasmania, Launceston, Tasmania, Australia.\', \'Department of Medicine, Launceston General Hospital, Tasmania, Australia; Department of Infectious Diseases, Launceston General Hospital, Tasmania, Australia.\', \'Department of Neurology, Launceston General Hospital, Tasmania, Australia; Faculty of Medicine, University of Tasmania, Launceston, Tasmania, Australia.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0165-5728(21)00246-010.1016/j.jneuroim.2021.577719
?:doi
?:hasPublicationType
?:journal
  • Journal of neuroimmunology
is ?:pmid of
?:pmid
?:pmid
  • 34560365
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.083
?:rankingScore_hIndex
  • 127
?:title
  • AstraZeneca COVID-19 vaccine and Guillain- BarrĂ© Syndrome in Tasmania: A causal link?
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all